Senior insider sale
Chief Executive Officer at MEREO BIOPHARMA GROUP PLC — senior position signals high conviction
$876.6K
221.64K shares
What this filing means
SCOTS-KNIGHT DENISE plans to sell 221.64K shares of MEREO BIOPHARMA GROUP PLC valued at approximately $876.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/12/2024ACC: 0000950170-24-105908
DirectorOfficer· Chief Executive Officer
Since Feb 2026
221.64K
Shares to sell
$876.6K
Approx. market value
188.06K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Same Day Cashless Exercise and Sale
Equity Compensation
9/12/2024
188.06KTotal acquired188.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/12/2024 | Same Day Cashless Exercise and Sale Equity Compensation | 188.06K | — |
| Total | 188.06K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
92.27K
Market value
$313.1K
6/26/2024
—Completed
Units to sell
40.71K
Market value
$150.4K
6/25/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
88.66K
Market value
$413.1K
9/12/2024
Total
Units
221.64K
Value
$876.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/26/2024 | 92.27K | $313.1K | — | Completed |
6/25/2024 | 40.71K | $150.4K | — | Completed |
| Planned — Approximate Date | ||||
9/12/2024 | 88.66K | $413.1K | NASDAQ | Planned |
| Total | 221.64K | $876.6K | ||